<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00274183</url>
  </required_header>
  <id_info>
    <org_study_id>94034</org_study_id>
    <nct_id>NCT00274183</nct_id>
  </id_info>
  <brief_title>Nonalcoholic Fatty Liver Disease in Taiwanese Children</brief_title>
  <official_title>Prevalence, Clinicopathological Characteristics, Biomarkers and Genetics of Nonalcoholic Steatohepatitis in Taiwanese Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Far Eastern Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Far Eastern Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nonalcoholic fatty liver disease (NAFLD) is an emerging and important disease in Taiwan.&#xD;
      However, the prevalence and clinical characteristics have not been studied well. The purpose&#xD;
      of this study is to resolve the aforementioned problem.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      [Study Subjects] Obesity was defined as the BMI value &gt; 95 percentile by different age- and&#xD;
      gender groups according to the standards of the Department of Health in Taiwan.&#xD;
&#xD;
      [Data Collection] The following data were obtained for each subject: age, gender, BMI, waist&#xD;
      and hip circumference. BMI was calculated as body weight (kg)/ height (m2).&#xD;
&#xD;
      In fasting venous blood samples, we measured total serum bilirubin, alanine aminotransferase,&#xD;
      aspartate aminotransferase, Î³-glutamyltransferase, fasting glucose, triglyceride, total&#xD;
      cholesterol,high-density lipoprotein cholesterol, insulin, glucose, and adiponectin.&#xD;
&#xD;
      [Liver Ultrasonography] All participants underwent an ultrasonographic study of the liver&#xD;
      performed by one operator.&#xD;
&#xD;
      NAFLD was defined as the presence of an ultrasonographic pattern consistent with the&#xD;
      following criteria: liver-kidney echo discrepancy, attenuated echo penetration and visibility&#xD;
      of diaphragm, and obscure hepatic vessel structures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2006</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>non-alcoholic fatty liver disease</measure>
    <time_frame>one year</time_frame>
    <description>confirmed by liver ultrasonography</description>
  </primary_outcome>
  <enrollment type="Actual">614</enrollment>
  <condition>Fatty Liver</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, WBC DNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Obese children will be enrolled from elementary school and high school in Taiwan&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of fatty liver&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  other hepatic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Cheng Lin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Far Eastern Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>January 2, 2006</study_first_submitted>
  <study_first_submitted_qc>January 2, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2006</study_first_posted>
  <last_update_submitted>April 7, 2019</last_update_submitted>
  <last_update_submitted_qc>April 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

